16
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Increased serum levels of carbohydrate-deficient transferrin in patients with chronic obstructive pulmonary disease

Pages 341-347 | Published online: 08 Jul 2009

REFERENCES

  • Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996; 80: 501–22.
  • Barnes PJ. Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmon-ary disease. Thorax 1999; 54: 245–52.
  • Rosenstein BJ, Zeitlin PL. Cystic fibrosis. Lancet 1998; 351: 277–82.
  • Witko-Sarsat V, Sermet-Gaudelus I, Lenoir G, Descamps-Latscha B. Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
  • Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999; 160:
  • Scanlin TF, Glick MC. Terminal glycosylation in cystic fibrosis. Biochim Biophys Acta 1999; 1455: 241–53.
  • Kukuruzinska MA, Lennon K. Protein N-glycosylation: molecular genetics and functional significance. Crit Rev Oral Biol Med 1998; 9: 415–48.
  • Landberg E, Pahlsson P, Lundblad A, Ametorp A, Jeppsson JO. Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. Biochem Biophys Res Commun 1995; 210: 267–74.
  • Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37: 2029–37.
  • de Jong G, Feelders R, van Noort WL, van Eijk HG. Transferrin microheterogeneity as a probe in normal and disease states. Glycoconj J 1995; 12: 219–26.
  • Larsson A, Flodin M, Kollberg H. Increased serum concentrations of carbohydrate-deficient trans-ferrin (CDT) in patients with cystic fibrosis. Ups J Med Sci 1998; 103: 231–6.
  • Montnemery P, Adelroth E, Heuman K, Johannisson A, Johansson SA, Lindholm LH, Lundback B, Lofdahl CG. Prevalence of obstruc-tive lung diseases and respiratory symptoms in southern Sweden. Respir Med 1998; 92: 1337–45.
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 Suppl 16: 5–40.
  • Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J. ER S—consen-sus statement. Optimal assessment and manage-ment of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398–420.
  • Jeppsson JO, Kristensson H, Fimiani C. Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin Chem 1993; 39: 2115–20.
  • Gravel P, Waltzer C, Aubry C, Balant LP, Yersin B, Hochstrasser DF, Guimon J. New alterations of serum glycoproteins and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. Biochem Biophys Res Commun 1996; 220: 78–85.
  • de Jong G, van Noort WL, Feeelders RA, de Jeu-Jaspars CMH, van Eijk HG. Adaptation of trans-ferrin protein and glycan synthesis. Clin Chim Acta 1992; 212: 27–45.
  • Randell E, Diamandis EP, Goldberg DM. Changes in serum carbohydrate-deficient transferrin and glutamyl transferase after moderate wine consump-tion in healthy males. J Clin Lab Anal 1998; 12: 92–7.
  • Lange P, Groth S, Mortensen J, Mortensen J, Appleyard M, Nyboe J, Jensen G, Schnohr P. Pulmonary function is influenced by heavy alcohol consumption. Am Rev Respir Dis 1988; 137: 1119–23.
  • Sparrow D, Rosner B, Cohen M, Weiss ST. Alcohol consumption and pulmonary function. A cross-sectional and longitudinal study. Am Rev Respir Dis 1983; 127: 735–8.
  • Pratt PC, Vollmer RT. The beneficial effect of alcohol consumption on the prevalence and extent of centrilobular emphysema. A retrospective autopsy analysis. Chest 1984; 85: 372–7.
  • Widerman E, Millner L, Sexauer W, Fiel S. Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years. Chest 2000; 118: 427–33.
  • Lakshman MR, Rao MN, Marmillot P. Alcohol and molecular regulation of protein glycosylation and function. Alcohol 1999; 19: 239–47.
  • Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limi-tation is associated with severity of airway inflam-mation in smokers. Am J Respir Crit Care Med 1998; 158: 1277–85.
  • Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000; 117 Suppl. 1: 286–91.
  • Jiang X, Hill WG, Pilewski JM, Weisz OA. Glycosylation differences between cystic fibrosis and rescued airway cell line are not CFTR depen-dent. Am J Physiol 1997; 273: 913–20.
  • Gasparini P, Savoia A, Luisetti M, Peona V, Pignatti PF. The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1990; 2:297–9.
  • Pignatti PF, Bombieri C, Mango C, Benetazzo M, Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated b ronch-iectasis. Hum Mol Genet 1995; 4: 635–9.
  • Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998; 351: 1911–3.
  • Sears P, Wong CH. Enzyme action in glycoprotein synthesis. Cell Mol Life Sci 1998; 54: 223–52.
  • Peroni DG, Djukanovic R, Bradding P, Feather IH, Montefort S, Howarth PH, Jones DB, Holgate ST. Expression of CD44 and integrins in bronchial mucosa of normal and mildly asthmatic subjects. Eur Respir J 1996; 9: 2236–42.
  • Holgate ST, Lackie PM, Davies DE, Roche WR, Walls AF. The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy 1999; 29 Suppl 2: 90–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.